“If you’re looking to minimize litigation risk, opt-in consent is realistically the only thing that works, said Elliot Golding, a partner at McDermott Will & Schulte. “But that’s a tough pill for a lot of marketing teams.
“If you’re looking to minimize litigation risk, opt-in consent is realistically the only thing that works, said Elliot Golding, a partner at McDermott Will & Schulte. “But that’s a tough pill for a lot of marketing teams.

